Journal of ethnopharmacology

Ligusticum officinale may reduce brain inflammation and behavior problems in Parkinson’s disease models

Updated

Abstract

L. officinale significantly attenuated the LPS-stimulated increase in inflammatory mediators in BV-2 cells.

  • Inhibition of nuclear factor-kappa beta activation was observed, along with blocking the degradation of IκB-α in BV-2 cells.
  • L. officinale suppressed the phosphorylation of p38-mitogen-activated protein kinase in response to LPS.
  • The extract exhibited antioxidant properties by inhibiting free radicals.
  • Prophylactic treatment with L. officinale in a mouse model of Parkinson's disease prevented microglial activation and improved behavioral outcomes.
  • HPLC analysis identified ferulic acid as a major component of L. officinale, which also inhibited proinflammatory mediator release.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free